VitriVax, Inc. announces $87 million Series C financing co-led by F-Prime, NEA, and others to advance its Lyme disease vaccine candidate into the clinic.
Amount Raised
$87 Million
Round Type
Series C
Investors
Description
VitriVax, Inc. has closed an oversubscribed $87 million Series C financing round. The investment was co-led by F-Prime, NEA, RA Capital Management, and Sanofi Ventures, with participation from Eli Lilly and Company and other existing investors. The funds will be used to advance VitriVax’s lead program, a Lyme disease vaccine with a novel mechanism of action
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Vitri Vax that raised within 45 days of this round, from Fundz verified event records.
- Commit Biologics raised $60M (Seed) on November 17, 2026.
- Onward Therapeutics SA raised $28M (Series B) on November 17, 2026.
- 201 Therapeutics raised $178K (Seed) on November 16, 2026.
- Seawolf Therapeutics raised $100M (Seed) on November 16, 2026.
- Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
- Yicura BioMed raised an undisclosed amount (Series B) on November 13, 2026.
Who to call at Vitri Vax, and when
A new round usually means Vitri Vax is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vitri Vax raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vitri Vax, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vitri Vax. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vitri Vax raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Vitri Vax raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.